​

Vyome Holdings Stock (NASDAQ:HIND)

RevenueOwnershipFinancialsChart
Vyome Holdings by TradingView

Previous Close

$2.19

52W Range

$1.75 - $18.60

50D Avg

$2.17

200D Avg

$3.23

Market Cap

$12.27M

Avg Vol (3M)

$26.01K

Beta

1.50

Div Yield

-

HIND Company Profile

Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

18

IPO Date

Oct 06, 2016

Website

HIND Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 18
Product$174.65K$606.71K
License$116.90K-
Royalty$28.17K-

Fiscal year ends in Dec 25 | Currency in USD

HIND Financial Summary

Dec 25Dec 24Dec 23
Revenue$319.71K$8.01M$8.68M
Operating Income$-10.35M$-7.73M$-14.64M
Net Income$-10.48M$-7.13M$-11.39M
EBITDA$-10.34M$-6.65M$-11.18M
Basic EPS-$-345.74$-2.77K
Diluted EPS-$-345.74$-2.77K

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 14, 24 | 4:30 PM
Q2 24Aug 15, 24 | 4:30 PM
Q1 24May 15, 24 | 4:30 PM

Peer Comparison

TickerCompany
IMDXInsight Molecular Diagnostics Inc.
CCCCC4 Therapeutics, Inc.
TNXPTonix Pharmaceuticals Holding Corp.
OABIOmniAb, Inc.
SGMOSangamo Therapeutics, Inc.
CDXSCodexis, Inc.
IPHAInnate Pharma S.A.
NVCTNuvectis Pharma, Inc.
CGENCompugen Ltd.